EFFECTIVNESS OF IRON CARBOXYMALTOSATE IN PATIENTS WITH HYPOFERRIC ANEMIA ON THE BACKGROUND OF UTERINE HEMORRHAGES. CLINICAL OBSERVATION

EFFECTIVNESS OF IRON CARBOXYMALTOSATE IN PATIENTS WITH HYPOFERRIC ANEMIA ON THE BACKGROUND OF UTERINE HEMORRHAGES. CLINICAL OBSERVATION

The article analyzes possibilities of hypoferric anemia in patients with abnormal uterine hemorrhages. Pathogenetic mechanisms of iron carboxymaltosate in therapy of this pathology are described. A clinical observation of a girl of a growing age with hypoferric anemia is presented and its clinical e...

Full description

Bibliographic Details
Main Authors:	N. A. Buralkina, Z. K. Batyrova, E. V. Uvarova, N. S. Ruseikin, I. A. Kiseleva
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2016-12-01
Series:	Медицинский совет
Subjects:	menstrual cycle abnormal uterine hemorrhages hypoferric anemia iron carboxymaltosate
Online Access:	https://www.med-sovet.pro/jour/article/view/1432

Similar Items

Ferric carboxymaltose solution versus iron sucrose complex in treating Iron-deficiency anemia patients with heavy uterine bleeding: A cost-efficacy study from a tertiary care hospital in the Kingdom of Saudi Arabia
by: Ayman Hejazi, et al.
Published: (2021-01-01)

Iron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
by: Vineet Mishra, et al.
Published: (2018-01-01)

Pain during Endometrial Sampling between Menstrual Regulator and Standard Uterine Curette
by: Surasak Angsuwathana, et al.
Published: (2004-08-01)

Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial
by: Ambily Jose, et al.
Published: (2019-02-01)

Efficacy and safety of intravenous ferric carboxymaltose in iron deficiency anemia; Real-life data from Turkey, a single center experience
by: Ali Eser, et al.
Published: (2021-06-01)

Effectiveness of intravenous ferric carboxymaltose in improving hemoglobin level among postpartum women with moderate-to-severe anemia at a secondary care hospital in Faridabad, Haryana – An interventional study
by: Shashi Kant, et al.
Published: (2020-01-01)

Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
by: Amreen Naqash, et al.
Published: (2018-01-01)

Abnormal uterine bleeding; its prevalence, causes and management in a tertiary care hospital
by: Shabir Ahmed Choudhury, et al.
Published: (2020-07-01)

New ways in therapy of abnormal uterine bleedings related to adenomyosis
by: N N Rukhliada, et al.
Published: (2015-06-01)

Relationship of Patterns of Abnormal Uterine Bleeding with Underlying Pathology
by: Fouzia Umber Qureshi, et al.
Published: (2018-12-01)

Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women
by: Jae-Yoon Shim, et al.
Published: (2018-08-01)

Hypophoshatemia Incidence in Patients with Chronic Kidney Disease Treated with Intravenous Ferric Carboxymaltose and Factors Related to Hypophosphatemia
by: Abdullah Şumnu, et al.
Published: (2020-09-01)

Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany
by: Froessler B, et al.
Published: (2018-04-01)

Approach to Abnormal Uterine Bleeding in Adolescents
by: Cenk Yaşa, et al.
Published: (2020-01-01)

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Patients with Postoperative Anemia Following Same-Day Bilateral Total Knee Arthroplasty: A Randomized Controlled Trial
by: Man Soo Kim, et al.
Published: (2021-04-01)

Fatal anaphylactic reaction due to ferric carboxymaltose: A case report
by: Aylin Mualla Arici, et al.
Published: (2020-07-01)

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up
by: Antonio Lacquaniti, et al.
Published: (2020-09-01)

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
by: Jesse M. G. Hofman, et al.
Published: (2018-09-01)

Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
by: Wendy Fang, et al.
Published: (2019-10-01)

Quality of life after hysterectomy and uterus-sparing hysteroscopic management of abnormal uterine bleeding or heavy menstrual bleeding
by: Sushma Selvanathan, et al.
Published: (2019-01-01)

Comparing the efficacy between ferrous carboxymaltose and iron sucrose therapy in iron deficiency anemia during pregnancy in Obstetrics and Gynecology ward at tertiary care hospital, Jaipur
by: Kamal Saini, et al.
Published: (2020-01-01)

A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose
by: Giuseppe Rosano, et al.
Published: (2020-11-01)

Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: A meta-analysis
by: Jamshed Dalal, et al.
Published: (2017-11-01)

Four years of experience in our clinic regarding hysteroscopies for abnormal uterine hemorrhages
by: Tina Bobei, et al.
Published: (2018-05-01)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
by: Adkinson NF, et al.
Published: (2017-09-01)

Assessing patient satisfaction levels following endometrial ablations in the treatment of abnormal uterine bleeding to determine effectiveness
by: Gonzalez, Sonia
Published: (2017)

Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status
by: Wendy Fang, et al.
Published: (2020-06-01)

Correlation between cytological and histopathological examination of the endometrium in abnormal uterine bleeding
by: Navjot Kaur, et al.
Published: (2014-01-01)

The Effect of Intraoperative Ferric Carboxymaltose in Joint Arthroplasty Patients: A Randomized Trial
by: Hee-Sun Park, et al.
Published: (2019-10-01)

Evaluation of iron stores in hemodialysis patients on maintenance ferric Carboxymaltose dosing
by: Matthias Diebold, et al.
Published: (2019-03-01)

Radiofrequency endometrial ablation with a novel endometrial tip for the management of heavy menstrual bleeding and abnormal uterine bleeding: a prospective study
by: Eun-Ju Lee, et al.
Published: (2020-01-01)

Short‐term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial‐IRON trial
by: Enrique Santas, et al.
Published: (2020-12-01)

Uterine bleedings and quality of woman's life
by: Ю. Г. Антипкін, et al.
Published: (2019-06-01)

Advances on minimally invasive approach for benign total hysterectomy: a systematic review [version 1; referees: 2 approved]
by: Marina de Paula Andres, et al.
Published: (2017-08-01)

Current trends in the pharmacotherapy of uterine myoma, associated with heavy menstrual bleeding and anemia: a literature review
by: Z. V. Revazova, et al.
Published: (2021-03-01)

Treatment of iron deficiency anemia in the preoperative preparation of patients with uterine myoma
by: T. A. Fedorova, et al.
Published: (2015-12-01)

Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding
by: Raquel Ballester-Clau, et al.
Published: (2020-04-01)

Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study
by: I. E. Emrich, et al.
Published: (2020-07-01)

Cardiovascular, liver, and renal toxicity associated with an intravenous ferric carboxymaltose similar versus the originator compound
by: Toblli JE, et al.
Published: (2017-11-01)

Diagnostic value of saline contrast sonohysterography comparing with hysteroscopy for detecting endometrial abnormalities in women with abnormal uterine bleeding
by: Farzaneh Goharzad, et al.
Published: (2011-01-01)

Cannot write session to /tmp/vufind_sessions/sess_df0ubqo62u5b0rqjb92j34lim8